...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM Corporation Update Slides and Webcast

Agreed! Except for the continued work in progress on the science front..the AGM was a zero for Zenith.....we want progress on liquidity....don't want an 18 year wait like RVX!

Share
New Message
Please login to post a reply